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Primary mucosal desmoplastic melanoma of the
gingiva

Nilüfer ÖZKAN4
Abstract: Desmoplastic melanoma (DM) is a very rare variant of malignant melanoma. Mucosal
involvement in DM is exceedingly rare and the differential diagnosis is problematic for surgical
pathologists. To the best of our knowledge only 16 cases of DM originating from mucosal surfaces
of the oral cavity have been described in the literature. Herein we describe a 59-year-old male with
primary DM of the oral mucosa and discuss the status of p53, caspase-3, and FasL (Fas ligand) in
the pathogenesis of this rare disease.
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Jinjivanın primer mukozal desmoplastik melanomu
Özet: Desmoplastik melanoma (DM) malign melanomanın çok nadir bir alt tipidir. Bu alt tip
mukozal yüzeylerde ileri derecede nadir olarak görülür ve ayırıcı tanısı cerrahi patologlar için
güçlük arz etmektedir. Literatürde, oral kavitenin mukozal yüzeylerinden kaynaklanan sadece 16
DM olgusu saptayabildik. Bu raporda, oral mukozanın primer DM’lı 59 yaşındaki erkek hastamızı
takdim ediyor ve bu nadir hastalığın patogenezinde p53, caspase-3 ve FasL’nin durumunu
tartışıyoruz.
Anahtar Sözcükler: Desmoplastik melanoma, oral mukoza, p53, FasL, caspase-3
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Desmoplastic melanoma (DM) of the skin was first described in 1971 (1).
DM constitutes 0.1% of all cutaneous melanomas (2). DM is characterized by
amelanotic invasive spindled cell morphology and a histopathological
appearance resembling soft tissue sarcomas, causing diagnostic confusion (3).
Conley et al. (1), who first described DM, suggested that this rare malignant
melanoma variant generally arises from chronically sun-damaged skin. In 1979
Batsakis et al. first described primary mucosal DM of the maxillary alveolus in
the absence of sunlight exposure (4). Only 1 case of mucosal origin in a series of
45 DM cases with head and neck involvement was reported (5).
In the English language literature only 16 cases of DM originating from the
oral mucosa have been reported (3,4,6-12). We report a 59-year-old male with
primary DM of the oral mucosa, because of the extreme rarity of this melanoma
variant and the diagnostic difficulties associated with it, and discuss the status of
p53 and expression of 2 important markers (caspase-3 and FasL) in the
alternative apoptosis pathway.
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Case Report
A 59-year-old male patient with an ulcerated
mass in the left-upper second premolar tooth
region was admitted to hospital. His complaints
had begun 5 years earlier and a punch biopsy
performed at that time was not diagnostic. His
complaints initiated with hemorrhagic mucosal
pigmentation of the oral cavity. The patient’s oral
hygiene was very poor. An ulcerated nodular
mass involving the left upper gingival alveolar arc
at the level of the second premolar tooth and hard
palate was detected on physical examination.
There was no cervical lymphadenopathy or
suspicious pigmented skin lesion. Incisional
biopsy
revealed
hyperplastic
squamous
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epithelium with prominent pigmented junctional
activity resembling lentigo maligna in situ, and
infiltration of predominantly spindle-shaped
atypical cells in the submucosa and deeper tissues
(Figure 1A, B). Atypical spindled and
melanocytic cells were strongly positive for
vimentin and S-100 (Figure 1C, D). The atypical
cells were negative for homatropine methyl
bromide antigen (HMB-45), low and high
molecular weight cytokeratins (LMWCK and
HMWCK), and leukocyte common antigen
(LCA). The patient was diagnosed with primary
mucosal malignant melanoma (MMM) of the oral
cavity on the basis of histopathological and
immunohistochemical findings.

A

B

C

D

Figure 1. A. Extensive and pigmented junctional activity in mucosal squamous epithelium (HE, 10×).
B. Atypical, spindled cell infiltration in deeper areas of the mucosal tissue (HE, 20×)
C. Extensive and strong positivity for vimentin in tumoral cells (AEC, 15×).
D. Strong S-100 positivity in junctional activity and spindled cell infiltration beneath squamous epithelium (AEC, 15×).
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Maxillary bone tomography revealed bone
destruction in the alveolar processes and hard palate
of the left maxillary bone, without involvement of
the base of the maxillary sinus. Subtotal maxillary
resection and reconstruction were performed. The
tumoral lesion primarily involved the hard palate
and also infiltrated gingival areas. The tumor
consisted of a nodular mass with an ulcerated
surface and elevated edges. At its widest point the
tumor was 55 mm. The tumor had a solid gray-white
cut surface with hemorrhagic foci and dark staining
areas. Surgical margins were macroscopically free of
the tumor. The tumor extensively infiltrated the
maxillary bone. Microscopic examination showed a
hyperplastic squamous epithelium layer with
extensive junctional activity (Figure 2A, B) and
extensive tumoral infiltration beneath the squamous
epithelium (Figure 2A). The tumor consisted of
spindled atypical cells, without pigmentation
(Figure 2C). An extensive fascicular pattern, and
focal whorled and nesting areas were also noted in
the sections. Most areas of the tumor had prominent
collagenous stroma between tumor cell fascicles
(Figure 2D). The tumor cells had pleomorphic,
hyperchromatic nuclei with some prominent
nucleoli (Figure 2E). The degree of nuclear atypia
was usually moderate, but marked pleomorphic
areas were also present. Mitotic activity was 4-5/10
high power fields and areas of focal necrosis were
present. The tumor cells with an epithelioid
appearance were fewer (Figure 2F). Focal perineural
infiltration areas were present (Figure 2G). Most of
the fascicular pattern areas resembled fibrosarcoma
and in some areas a malignant peripheral nerve
sheath tumor.
HMB-45, desmin, caldesmon, calponin, alpha-1
antitrypsin, HMWCK, p53, caspase-3, and FasL
antibodies in the tumor were analyzed. Several
tumor cells reacted to HMB-45, both in spindled
and epithelioid cell areas (Figure 2H). Both
epithelioid and spindled cell areas were diffusely
positive for FasL (Figure 2I). Focal expression (15%20% tumor cells) for p53 was determined (Figure
2J). The tumor cells were negative for the other
antibodies.
These histopathological and immunohistochemical findings in both the punch biopsy and
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resection material were consistent with a diagnosis
of primary MMM of the oral cavity. The findings of
prominent collagenous stroma, a fascicular pattern,
absence of melanin pigment, and atypical
melanocytic proliferation areas in the basal layer of
squamous epithelium, supported the diagnosis of
primary mucosal DM. Local recurrence in the left
buccal region (previous area of the surgery) and
lymph node metastasis in the left neck occurred in
the ninth month following surgery. Aspiration
cytology revealed atypical epithelioid and spindled
cells, and stromal fragments. Cell nuclei were round
and oval with coarse chromatin, and devoid of
nucleoli. Aspiration biopsies from both lesions
confirmed the recurrence and metastasis of
malignant melanoma (Figure 3). At the time of
writing, the patient is being treated with
radiotherapy, chemotherapy, and meticulous
follow-up examinations.
Discussion
The desmoplastic variant of melanoma is very
rare and primary DM of the oral mucosa is
exceedingly rare. DM may be frequently confused
with non-melanocytic spindle cell tumors. We
suggest that the disease may be underreported
because of the difficulty in histopathological
diagnosis. The Table shows the distribution of
reported cases of primary mucosal DM of the oral
cavity, according to compartments of the oral cavity.
Maxillary gingival location was the most common
origination site. In the presented case left maxillary
gingival mucosa, hard palate, and left maxillary bone
involvement were observed. A male predominance,
with a male/female ratio of 3:1, was noted. The age
range of diagnosed cases was 23-75 years. DM tends
to occur in middle- and older-aged males.
DM has various microscopic morphologies and
often resembles mesenchymal tumors, such as
fibrosarcoma, malignant peripheral nerve sheath
tumor, leiomyoma, or sarcomatous squamous cell
carcinoma. The histology of DM is characterized by
spindled cell proliferation, with variable cellularity
(1,5,13-15). The cellular arrangement usually
consists of interlacing fascicles and whorls. DM
exhibits nuclear/cellular pleomorphism, varying in
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Figure 2. A. Extensive spindle-shaped cell infiltration beneath hyperplastic squamous epithelium (HE, 6×).
B. Extensive junctional activity in the basal layer of squamous epithelium (HE, 16×).
C. Fascicular pattern of spindled cells in the tumor (HE, 20×).
D. Extensive desmoplastic stromal areas in the tumor (HE, 10×).
E. Atypical spindled cells, with vesicular nuclei and prominent nucleoli. Mitotic figures were frequently noted (HE, 30×).
F. Atypical cells with epithelioid appearance in the tumor (HE, 40×).
G. Perineural invasion in the tumor (HE, 30×).
H. Rare focal cytoplasmic positivity for HMB-45 (AEC, 40×).
I. Diffuse, strong cytoplasmic positivity for FasL in the tumor (AEC, 20×).
J. Focal nuclear p53 positivity in the tumor (AEC, 60×).
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A

B
Figure 3. A. Epithelioid and spindled cells around and within the
stromal component in an aspiration smear (MGG, 30×).
B. The cell groups consisted of pleomorphic and
hyperchromatic nuclei, devoid of nucleoli. Pigment
accumulation was not observed in any areas (MGG, 30×).
Abbreviations; HE; Hematoxylin-eosin; AEC; amino-ethylcarbozole; MGG; May Grünwald giemsa.

degree from mild to severe. Whereas nuclear
enlargement, a coarse chromatin pattern, and
irregular nuclear membranes are common
cytological features, large nucleoli are rare. The
absence of melanin pigment is another characteristic
feature. The lack of macro-nucleoli and melanin
pigment are 2 factors that make the diagnosis of DM
difficult.
The most important clue for diagnosis may be
squamous epithelium of the oral mucosa, especially
in the basal cell layer, with atypical melanocytic
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proliferation in the form of junctional activity or
pagetoid infiltration. Mucosal surfaces may have
foci of lentigo maligna melanoma in situ.
Collagenous stroma is invariably present and
collagenous content may be very high. Because of
the desmoplastic stromal response, atypical spindle
cells may have a relatively bland cytological
appearance and may be mistakenly considered
benign. High cellular areas may resemble soft tissue
tumors. The differential diagnosis includes benign
soft tissue tumors and tumor-like processes, such as
dermatofibroma, schwannoma, neurofibroma,
leiomyoma, fibromatosis, and reparative processes.
High cellularity, evident nuclear atypia, high mitotic
rate, and necrosis indicate the diagnosis of DM.
Fibrosarcoma, malignant fibrous histiocytoma, and
leiomyosarcoma, as well as sarcomatous variant
squamous cell carcinoma should also be considered
in the differential diagnosis of DM (5,15,16). Lack of
cytoplasmic melanin pigment, loss of melanoma in
situ focus in ulcerated mucosa areas, and lack of
other specific histological characteristics of DM may
result in difficulty diagnosing DM. In situ carcinoma
or invasive squamous cell carcinoma foci may help
in the diagnosis of the sarcomatous variant of
squamous cell carcinoma. Ancillary methods may
also aid diagnosis.
A panel of immunohistochemical markers may
serve to discriminate DM from other amelanotic
spindled cell tumors. Vimentin and S-100 are
invariably positive in DM. HMB-45, a specific
marker for melanoma, is usually negative in DM. On
the other hand, epitheloid areas of DM may show
mild to moderate positivity. Alpha-1 antitrypsin is a
specific marker for malignant fibrous histiocytoma,
whereas caldesmon and calponin may be useful in
the diagnoses of leiomyosarcoma and fibrosarcoma,
respectively. The sarcomatous variant of squamous
cell carcinoma may be identified by cytokeratin
positivity. The differentiation of DM from MPNST
may be very difficult or even impossible, because
both tumors have many overlapping features. DM
exhibits evidence of Schwannian differentiation,
both at ultrastructural and light microscopic levels
(5,13,17,18). Both tumors are positive for S-100 and
negative for HMB-45 (5,19). Clinical data, such as a
previous history of a pigmented mucosal lesion, the
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Table. The cases of primary mucosal desmoplastic melanoma of the oral cavity reported in the literature.
Case
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.

Age

Gender

60
59
24
58
66
42
64
75
60
53
74
34
23
61
73
54
59

M
F
M
M
F
M
M
M
M
F
M
M
F
M
M
M
M

Localization

Report date/author

Maxillary alveolar mucosa
Palatal mucosa, gingiva
Palatal mucosa
Maxillary gingival mucosa
Maxillary gingival mucosa
Maxillary mucosa
Maxillary mucosa
Lower lip mucosa
Lower lip mucosa
Palatal alveolar mucosa
Buccal mucosa
Maxillary gingival mucosa
Lower (mandible) gingival mucosa
Lower lip mucosa
Lower (mandible) gingival mucosa
Lower lip mucosa
Maxillary gingival mucosa

1979/Batsakis et al .
1983/Saku et al.
1989/Chen et al.
1992/Kurihara et al.
1996/Ueta et al.
1996/Kilpatrick et al.
1996/Kilpatrick et al.
1996/Kilpatrick et al.
1998/Madrigal et al.
2000/Kavanagh et al.
2004/Prasad et al.
2004/Prasad et al.
2004/Prasad et al.
2004/Prasad et al.
2004/Prasad et al.
2004/Prasad et al.
Present case

Ref.
4
6
7
8
9
10
10
10
11
12
3
3
3
3
3
3

Abbreviations; M; Male; F; female; Ref; references.

presence of lymph node metastasis, and a history of
neurofibromatosis,
may
facilitate
their
differentiation (16,20,21). As both entities are of
neural crest origin and are aggressive, some
researchers suggest that differentiating these 2
entities is unnecessary (16,20).
The presented case also had similar areas of
MPNST, especially in the deep portions of the
tumor, and these foci alternated as hypocellular and
hypercellular areas. The lack of nuclear palisading
and clinical history/findings in our patient excluded
the diagnosis of MPNST. Areas of reminiscent
fibrosarcoma, MFH, and leiomyosarcoma were also
present in our case, but prominent storiform,
herringbone patterns, and extensive necrotic areas
were not observed. In addition, areas resembling
malignant mesenchymal tumors were also negative
for calponin, caldesmon, desmin, and alpha-1
antitrypsin. In the presented case S-100 and
vimentin were diffusely positive, while HMB-45 was
focally positive. These immunohistochemical
findings and histological features (melanoma in situ
foci, amelanotic spindled cells with mostly bland
cytological features, desmoplastic stromal response,
and neurotropism) were indicative of the diagnosis
of primary mucosal DM.
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The literature contains only 2 reports describing
the cytological features of DM (22,23). Nance et al.
(22) emphasized the presence of microtissue
fragments of spindle cells with hyperchromatic
nuclei and prominent nucleoli in aspiration smears.
Chhieng et al. (23) reported predominantly isolated
spindle cells with a bland nuclear appearance in the
smears. The same authors reported that some
spindle cells had moderate nuclear atypia based on
retrospective examination of the same smears (23).
Intracytoplasmic pigmentation and intranuclear
inclusion were absent in both cases (22,23).
Aspiration material from a recurrent mass in the
buccal region of the presented case at the ninth
postoperative month follow-up showed cytological
findings similar to 2 previously reported cases.
Aspiration smears were strongly cellular, and
atypical spindled and epithelioid cells with
pleomorphic nuclei without nucleoli were observed.
Surgery, especially complete resection of mucosal
DM of oral cavity, is very difficult because of the
complex anatomy and the great propensity for
neurotropism (3). Neurotropism predisposes to
recurrence. A recurrence rate of 100% was reported
in patients with primary DM of the oral cavity by
Prasad et al. (3), who reported the largest series of
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primary mucosal DM of the oral cavity in the
literature. This rate was higher than in cutaneous
DM, which has a recurrence rate of about 33% (24).
Regional and distant metastases may be seen in DM
of the oral cavity. In the series by Prasad et al. (3) 3
cases had regional and/or distant metastases.
Smithers et al. (24) reported that the distant
metastasis rate was 19% in cutaneous DM. Similarly,
Prasad et al. (3) reported that patients with
cutaneous DM may have a better prognosis than
those with conventional mucosal melanoma. The 5year disease-specific survival rate in their series was
57% (median: 8 years). This rate was reported as
42% (median: 2.4 years) in 2 previous studies by the
same authors, which included all primary mucosal
melanomas of the head and neck (25,26). Our
patient had a 69-month history of primary mucosal
DM, with recurrence and lymph node metastasis at
the ninth month after resection.
The development of malignancies, and resistance
to chemotherapy and radiotherapy are complicated
processes in which apoptosis and apoptosis-related
genes are of crucial importance. Mutations in the
p53 gene have been observed in only a minority of
cutaneous melanomas (17.6%) and primary mucosal
melanomas (28.6%) (27). Expression of p53 was
noted in 37% of primary non-desmoplastic mucosal
melanomas (28). Prasad et al. (3) observed p53
expression in 6 cases (86%) out of 7 of DM. This rate
was much higher than for those of non-desmoplastic
cutaneous and mucosal melanomas. In the series by
Prasad et al. (3), among 6 cases of p53 expression, 4
cases had intense expression (> 50% tumor cells),
while focal p53 expression (6%-25% tumor cells)
was detected in 2 cases. The presented case had focal
p53 expression (15%-20% tumor cells).
Apoptosis occurs via 2 primary pathways. The
first involves the extrinsic or cytoplasmic pathway.
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The extrinsic pathway is triggered by death receptors.
The second apoptosis pathway involves intrinsic
mitochondrial damage, the release of cytochrome c,
and activation of caspase-9. Activation of caspase-3 is
closely related to that of caspase-9 (29). The Fas/FasL
system in the extrinsic pathway is a major pathway
for the induction of apoptosis (30). In a study by
Redondo et al. (30) Fas expression was highly variable
in primary melanomas, but the absence of Fas
expression in metastatic lesions was the most
noteworthy finding. This finding is a phenomenon
that has previously been reported, and it was
suggested that reduced Fas expression may be related
to a metastatic phenotype (31). Hahne et al. (31)
reported that FasL is expressed by human melanoma
cells. FasL is not expressed by normal melanocytes of
the skin, indicating that FasL upregulation probably
occurs during tumorigenesis (30). Most studies have
reported intense FasL expression in metastatic foci of
melanomas (31,32-35). In the presented case, FasL
expression was widespread and strongly positive.
Nonetheless, caspase-3 expression was not observed
in the tumor. Extensive strong FasL expression in the
tumor in the presented case might have been
associated with the progressive prognosis of DM.
This variant of malignant melanoma, with variable
clinical and prognostic features, may have a different
apoptosis pathway than other variants of malignant
melanoma.
In conclusion, we presented primary mucosal
DM of the oral cavity in a 59-year-old-male patient.
The diagnosis was established on the basis of
histopathological, immunohistochemical, and
clinical findings. The differential diagnosis may be
difficult because of the similarity of the
morphological features of DM and other soft tissue
tumors.
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